Home » Posts tagged 'biopharmaceutical sector'
Tag Archives: biopharmaceutical sector
The Mexico City “voluntary codes of business ethics” was recently adopted by Food and Drugs Administration. Under FDA Circular no. 2013-024, dated September 5, 2013, ethical violations are grounds for filing appropriate administrative charges and/or imposition of administrative sanctions such as, but not limited to, imposition of fines, suspension, cancellation or revocation of any license, permit or registration issued by FDA.
The circular was issued as a result of the 17th APEC Small and Medium Enterprise (SME) Ministerial Meeting, where the “The Mexico City Principles” was endorsed. The principles aim to: